LRRK2-IN-1

Overview

LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC 50 of 6 nM and 13 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > LRRK2 | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-10875
• CAS No.: 1234480-84-2
• Molecular Formula: C31H38N8O3
• Molecular Weight: 570.69
• Purity: 99.04%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 2.5 mg/mL (4.38 mM); Clear solution
• Availability: In-stock

Source

Original product source